William H. Mayo Iii

Array ( [id] => 1548556 [patent_doc_number] => 06346247 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-12 [patent_title] => 'Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies' [patent_app_type] => B1 [patent_app_number] => 09/429511 [patent_app_country] => US [patent_app_date] => 1999-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6980 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/346/06346247.pdf [firstpage_image] =>[orig_patent_app_number] => 09429511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4296607 [patent_doc_number] => 06251393 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Conformation-specific anti-von Willebrand Factor antibodies' [patent_app_type] => 1 [patent_app_number] => 9/421045 [patent_app_country] => US [patent_app_date] => 1999-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2603 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/251/06251393.pdf [firstpage_image] =>[orig_patent_app_number] => 421045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4324225 [patent_doc_number] => 06331613 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-18 [patent_title] => 'Isolated nucleic acid molecules which encode T cell inducible factors (TIFS), the proteins encoded, and uses thereof' [patent_app_type] => 1 [patent_app_number] => 9/419568 [patent_app_country] => US [patent_app_date] => 1999-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13037 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/331/06331613.pdf [firstpage_image] =>[orig_patent_app_number] => 419568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1446457 [patent_doc_number] => 06368857 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-09 [patent_title] => 'Method for provoking proliferation of cytolytic T cells via the use of decapeptides which complex with HLA-A2 molecules' [patent_app_type] => B1 [patent_app_number] => 09/412928 [patent_app_country] => US [patent_app_date] => 1999-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 7415 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/368/06368857.pdf [firstpage_image] =>[orig_patent_app_number] => 09412928 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4404098 [patent_doc_number] => 06264949 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Noninvasive agents for diagnosis and prognosis of the progression of fibrosis' [patent_app_type] => 1 [patent_app_number] => 9/406641 [patent_app_country] => US [patent_app_date] => 1999-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5229 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/264/06264949.pdf [firstpage_image] =>[orig_patent_app_number] => 406641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1419612 [patent_doc_number] => 06514938 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-04 [patent_title] => 'Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use' [patent_app_type] => B1 [patent_app_number] => 09/405743 [patent_app_country] => US [patent_app_date] => 1999-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 17 [patent_no_of_words] => 12141 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/514/06514938.pdf [firstpage_image] =>[orig_patent_app_number] => 09405743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1602002 [patent_doc_number] => 06432409 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-13 [patent_title] => 'Hybrid peptides modulate the immune response' [patent_app_type] => B1 [patent_app_number] => 09/396813 [patent_app_country] => US [patent_app_date] => 1999-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14991 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/432/06432409.pdf [firstpage_image] =>[orig_patent_app_number] => 09396813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1301159 [patent_doc_number] => 06624295 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-23 [patent_title] => 'Human anti-factor IX/IXa antibodies' [patent_app_type] => B1 [patent_app_number] => 09/383667 [patent_app_country] => US [patent_app_date] => 1999-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 21 [patent_no_of_words] => 25579 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/624/06624295.pdf [firstpage_image] =>[orig_patent_app_number] => 09383667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4314057 [patent_doc_number] => 06242419 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-05 [patent_title] => 'Compositions isolated from stromal cells and methods for their use' [patent_app_type] => 1 [patent_app_number] => 9/383586 [patent_app_country] => US [patent_app_date] => 1999-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21012 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/242/06242419.pdf [firstpage_image] =>[orig_patent_app_number] => 383586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4352560 [patent_doc_number] => 06190670 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-20 [patent_title] => 'Use of mCRP to enhance immune responses' [patent_app_type] => 1 [patent_app_number] => 9/376628 [patent_app_country] => US [patent_app_date] => 1999-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7671 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/190/06190670.pdf [firstpage_image] =>[orig_patent_app_number] => 376628 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4404114 [patent_doc_number] => 06264950 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Product and process for T lymphocyte immunosuppression' [patent_app_type] => 1 [patent_app_number] => 9/375419 [patent_app_country] => US [patent_app_date] => 1999-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 21906 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/264/06264950.pdf [firstpage_image] =>[orig_patent_app_number] => 375419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1599855 [patent_doc_number] => 06475749 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-05 [patent_title] => 'Rh hybrid antibody' [patent_app_type] => B1 [patent_app_number] => 09/372425 [patent_app_country] => US [patent_app_date] => 1999-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 6383 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 153 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/475/06475749.pdf [firstpage_image] =>[orig_patent_app_number] => 09372425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1576755 [patent_doc_number] => 06447771 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-10 [patent_title] => 'Methods and materials relating to novel CD39-like polypeptides' [patent_app_type] => B1 [patent_app_number] => 09/370265 [patent_app_country] => US [patent_app_date] => 1999-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 37810 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/447/06447771.pdf [firstpage_image] =>[orig_patent_app_number] => 09370265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1586975 [patent_doc_number] => 06359117 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-19 [patent_title] => 'Isolated nucleic acid molecules which encode T cell inducible factors (TIFs), the proteins encoded, and uses therefor' [patent_app_type] => B1 [patent_app_number] => 09/354243 [patent_app_country] => US [patent_app_date] => 1999-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11447 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/359/06359117.pdf [firstpage_image] =>[orig_patent_app_number] => 09354243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1473997 [patent_doc_number] => 06387645 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-14 [patent_title] => 'Methods and materials relating to novel CD39-like polypeptides' [patent_app_type] => B1 [patent_app_number] => 09/350836 [patent_app_country] => US [patent_app_date] => 1999-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 19162 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/387/06387645.pdf [firstpage_image] =>[orig_patent_app_number] => 09350836 [rel_patent_id] =>[rel_patent_doc_number] =>)